One of the highlights of Eli Lilly's third-quarter results ... described as "viral" take-up by the drugmaker. Lilly's head of diabetes, Mike Mason, said on the company's results call that the ...

Two years ago, Eli Lilly started working with Dexcom ... insulin therapy is still overwhelming and complex,” said Mike Mason, who heads Lilly’s connected care and insulins programme.

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the United States ...

(Reuters) -Eli Lilly plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker said at a Washington press conference on Wednesday, as it grapples with ...

Eli Lilly and Co. Wednesday announced plans to build four pharmaceutical manufacturing sites in the United States, significantly boosting domestic medicine production and adding around 13,000 ...